期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
匹伐他汀与阿托伐他汀对冠状动脉旁路移植术后早期患者调节血脂的对比研究 被引量:5
1
作者 冯翔 姜睿 +3 位作者 王少也 许建屏 杨研 潘世伟 《心脏杂志》 CAS 2018年第4期415-417,429,共4页
目的对比匹伐他汀(2 mg)和阿托伐他汀(20 mg)对冠状动脉旁路移植术(CABG)后早期血脂控制的效果及安全性。方法以单中心非盲随机对照的方式对196位受试者开展为期12周的临床研究。结果术后12周匹伐他汀组和阿托伐他汀组的总胆固醇(TC),... 目的对比匹伐他汀(2 mg)和阿托伐他汀(20 mg)对冠状动脉旁路移植术(CABG)后早期血脂控制的效果及安全性。方法以单中心非盲随机对照的方式对196位受试者开展为期12周的临床研究。结果术后12周匹伐他汀组和阿托伐他汀组的总胆固醇(TC),低密度脂蛋白胆固醇(LDL-C)和三酰甘油(TG)较基线水平均显著降低(均P<0.05),但组间无显著差异;两组患者的高密度脂蛋白胆固醇(HDL-C)较基线水平有所升高(P<0.05),但组间无显著差异;术后1周时,两组的丙氨酸氨基转氨酶(ALT),门冬氨酸氨基转氨酶(AST)及肌酸激酶(CK)较基线水平均有所升高,但阿托伐他汀组的ALT及CK较匹伐他汀组更高;术后12周匹伐他汀组的ALT,AST及CK较基线水平无显著变化,阿托伐他汀的ALT及CK较基线水平增高,但两组间无显著差异。结论 2 mg匹伐他汀与20 mg阿托伐他汀有相似的降低TC,LDL-C,TG及升高HDL-C的作用。 展开更多
关键词 匹伐他汀 阿托伐他汀 冠状动脉旁路移植术 血脂
下载PDF
Inflammatory abdominal aortic aneurysm: clinical features and long term outcome in comparison with atherosclerotic abdominal aortic aneurysm 被引量:3
2
作者 YIN Ming-di ZHANG Jian +2 位作者 wang shao-ye DUAN Zhi-quan XIN Shi-jie 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第10期1255-1258,共4页
Background Inflammatory abdominal aortic aneurysms (IAAAs) are rare but distinct clinical entities of atherosclerotic abdominal aortic aneurysms (aAAAs). In this study we report a 20-year single institution experi... Background Inflammatory abdominal aortic aneurysms (IAAAs) are rare but distinct clinical entities of atherosclerotic abdominal aortic aneurysms (aAAAs). In this study we report a 20-year single institution experience for IAAA and analyze their clinical features and long term outcome in comparison with aAAA. Methods Between 1988 and 2008, 412 cases of abdominal aortic aneurysms (AAAs) underwent elective surgical operations, 11 (2.7%) of whom were diagnosed as IAAAs and 389 (94.4%) were diagnosed as aAAAs. The former group was matched in a case control fashion to a group of 33 patients with aAAAs having similar characteristics of age, gender, and preoperative risk factors. All available clinical, pathologic, and postoperative variables were retrospectively reviewed, and the two groups were compared. Results The two groups did not differ significantly in clinical characteristics and preoperative risk factors, although patients with IAAAs were significantly more symptomatic (100% vs. 42.4%, P=0.001) and had larger aneurysms on admission ((7.4±0.7) cm vs. (6.3±0.9) cm, P=0.006). In IAAAs, the preoperative erythrocyte sedimentation rate was found to be significantly elevated compared to aAAA group ((44.5±9.1) mm/h vs. (11.4±5.4) ram/h, P 〈0.05). Surgical morbidity and mortality rates did not differ between the two groups. The operation time for patients with IAAAs was significantly longer than that for patients with aAAAs ((308±36) minutes vs. (224±46) minutes, P 〈0.05), but the cross-clamp time was similar in both groups ((41.5±6.2) minutes vs. (41.8±8.2) minutes, P=0.92). A five-year survival rate analysis showed no significant difference between the two groups (P=0.711). Conclusions Despite having more symptoms, larger size and longer operation time, patients with IAAA can now be treated with approaches that cause low morbidity and mortality, similar to patients with aAAA. Long term outcome of IAAA patients is of no difference from aAAA patients. 展开更多
关键词 ANEURYSM AORTIC INFLAMMATORY ATHEROSCLEROSIS
原文传递
Endovascular repair of a tuberculous aneurysm of descending thoracic aorta
3
作者 wang Yong ZHANG Jian +3 位作者 YIN Ming-di wang shao-ye DUAN Zhi-quan XIN Shi-jie 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第14期2228-2230,共3页
Tuberculous aortic aneurysm (TBAA) is an extremely rare clinical event with life-threatening implication. Management for this condition is challenging and its therapeutic option has not been yet established. A few r... Tuberculous aortic aneurysm (TBAA) is an extremely rare clinical event with life-threatening implication. Management for this condition is challenging and its therapeutic option has not been yet established. A few recent reports described endovascular repair rather than open surgery as the method for treatment. Although this remains controversial,endovascular exclusion has been gaining acceptance for some surgeons. We present a case of TBAA who was treated by endovascular stent grafting for a descending thoracic aortic aneurysm with simultaneous anti-tuberculous medication.The outcome was favorable. 展开更多
关键词 TUBERCULOSIS aneurysm of descending thoracic aorta STENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部